A. Serra

Atypical renal presentation of antiphospholipid syndrome

P. Correia, A. Gaspar, R. Manso, 2017 .

Cost-Effectiveness of Treating Patients with Chronic Kidney Disease and Prior Hyperkalemia with Renin–Angiotensin–Aldosterone System Inhibitor and Patiromer: A Swiss Public Healthcare Perspective

H. Telser, A. Serra, B. Fischer, 2022, Advances in Therapy.

Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy.

R. Mignani, S. Feriozzi, A. Pisani, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Failure of G-CSF therapy in neutropenia associated with Sjögren's syndrome.

J. Vivancos, M. Vila, A. Serra, 2002, Rheumatology.

Vasculitis affecting the kidney: presentation, histopathology and long-term outcome.

C. Brown, B. Hartley, J. Cameron, 1984, The Quarterly journal of medicine.

Myasthenia gravis exacerbation after red yeast rice use.

J. Ruel, A. Serra, A. Dopter, 2018, Revue neurologique.

Clinical and pathologic aspects of renal vasculitis.

J. Cameron, A. Serra, 1985, Seminars in nephrology.

Biomarkers in Fabry Disease

A. Serra, 2010 .

Recombinant ADAMTS13 for Hereditary Thrombotic Thrombocytopenic Purpura.

M. Tinguely, A. Licht, L. Asmis, 2022, The New England journal of medicine.